ANI Pharmaceuticals, Inc. (ANIP)
78.07
+1.59
(+2.08%)
USD |
NASDAQ |
Apr 16, 16:00
78.20
+0.13
(+0.17%)
After-Hours: 20:00
ANI Pharmaceuticals Free Cash Flow : 150.90M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liquidia Corp. | -40.02M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Indivior Pharmaceuticals, Inc. | -94.86M |
| Replimune Group, Inc. | -283.27M |
| ADMA Biologics, Inc. | 27.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 30.37M |
| Cash from Investing (Quarterly) | -1.403M |
| Cash from Financing (Quarterly) | -4.636M |
| Free Cash Flow Per Share (Quarterly) | 1.330 |
| Free Cash Flow to Equity (Quarterly) | 32.26M |
| Free Cash Flow to Firm (Quarterly) | 35.91M |
| Free Cash Flow Yield | 9.29% |